Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

VGLL1 KO in colon cancer cells primary culture clone E3, clone 22

ABSTRACT: In order to explore the potential role of VGLL1 in metastasis we knocked it out using CRISPR. Here we performed an RNAseq of the mutated cells and the wt cells to have an overview of the transcriptome regulation of cells without VGLL1 protein.

ORGANISM(S): Homo sapiens

PROVIDER: GSE278411 | GEO | 2025/12/10

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

VGLL1 KO in colon cancer cells primary culture clone E3, clone 22

Project description:VGLL1 KO in colon cancer cells primary culture clone E3, clone 22

| PRJNA1167204 | ENA

ATP11C Knock down in clone E3 from colon cancer CC14 primary culture

Project description:In order to explore the role of ATP11C in the metastatic potential of the highly metastatic clone E3 we knocked it down using an shRNA in a lentiviral backbone. Here we aimed to explore the transcriptome of E3 cells on which the expression of ATP11C has been knocked down.

2025-12-10 | GSE236692 | GEO

CSAG1 Knock out in clone E3 from colon cancer CC14 primary culture

Project description:In order to explore the role of CSAG1 in the metastatic potential of the highly metastatic clone E3 we knocked it out using CRISPR/Cas9 system . Here we aimed to explore the transcriptome of E3 cells on which the expression of CSAG1 has been supressed.

2025-12-10 | GSE236691 | GEO

VGLL1 drives therapy resistance in estrogen receptor positive breast cancer [RNA-Seq 3]

Project description:To investigate the function of VGLL1 in breast cancer and its role in the resistance to endocrine therapies we generated stable MCF7 cells overexpressing VGLL1 using CRISPR/Cas9 Synergistic Activation Mediator (SAM) method (MCF7 ActCas9-VGLL1 cells). MCF7 ActCas9-VGLL1 cells were also cultured in the presence of fulvestrant 100nmM or 1µM to develop fulvestrant resistant cells (MCF7 ActCas9-VGLL1-FULVR) and RNA-seq was performed in the different cell lines.

2023-12-05 | GSE216528 | GEO

VGLL1 drives therapy resistance in estrogen receptor positive breast cancer [ChIP-Seq]

Project description:The transcriptional activity of the TEAD4 trascription factor requires co-activators. In this study we found that the expression of the TEAD coactivator VGLL1 is repressed in estrogen receptor positive breast cancer but upon resistance to endocrine threapies VGLL1 is expressed to high levels. To elucidate the importance of the coactivator VGLL1 in breast cancer cells resistant to endocrine therapies and to identify the VGLL1 target genes, we performed ChIP-seq for VGLL1 in MCF7 breast cancer cells resistant to fulvestrant (FULVR) and ChiP-seq for TEAD4 in FULVR cells and the isogenic MCF7 cells.

2023-12-05 | GSE216525 | GEO

VGLL1 regulates extraembryonic lineage specification in human [ATAC-Seq]

Project description:Placenta abnormality is one of the key reasons for early pregnancy loss but the regulatory mechanisms underlying placenta formation are largely unknown. Here, we applied a human naïve pluripotent stem cell (PSC) derived TE model to explore the driven regulatory machinery. We demonstrate that VGLL1 (vestigial like family member 1) is crucial for TE self-renewal and TE-specific gene expression, thus suppressing VGLL1 leads to severely impaired cell proliferation and skewed TE induction. VGLL1 exerts its function through interacting with TEAD4 (TEA domain transcription factor 4) and colocalize at target gene promoters and enhancers. Further investigation uncovers the enrichment of H3K27ac active histone marks at genomic regions occupied by VGLL1-TEAD4 complex, indicates a close association between them. Overall, our data reveals the critical function model of VGLL1-TEAD4 in human TE derivation, highlighting a potential interspecies difference between human and mouse TE induction.

2023-12-18 | GSE193612 | GEO

VGLL1 regulates extraembryonic lineage specification in human [RNA-Seq]

2023-12-18 | GSE193619 | GEO

VGLL1 regulates extraembryonic lineage specification in human [CUT&TAG]

2023-12-18 | GSE193618 | GEO

VGLL1 regulates extraembryonic lineage specification in human [RNA-seq II]

Project description:Placenta abnormality is one of the key reasons for early pregnancy loss but the regulatory mechanisms underlying placenta formation are largely unknown. Here, we applied a human naïve pluripotent stem cell (PSC) derived TE model to explore the driven regulatory machinery. We demonstrate that VGLL1 (vestigiallikefamilymember1) is crucial for TE self-renewal and TE-specific gene expression, thus suppressing VGLL1 leads to severely impaired cell proliferation and skewed TE induction. VGLL1 exerts its function through interacting with TEAD4 (TEA domain transcription factor 4) and colocalize at target gene promoters and enhancers. Further investigation uncovers the enrichment of H3K27ac active histone marks at genomic regions occupied by VGLL1-TEAD4 complex, indicates a close association between them. Overall, our data reveals the critical function model of VGLL1-TEAD4 in human TE derivation, highlighting a potential interspecies difference between human and mouse TE induction.

2023-12-18 | GSE241813 | GEO

VGLL1 drives therapy resistance in estrogen receptor positive breast cancer [RNA-Seq 2]

Project description:To identify VGLL1 target genes we performed RNA-seq following siRNA-mediated VGLL1 downregulation in FULVR cells.

2023-12-05 | GSE216527 | GEO